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1. Introduction 
In a previous paper [l] it was shown that elonga- 
tion factors with GTP increase the resistance of 
translating ribosomes to inhibitors. It was found that 
the elongation factor T, (EF-T,) with GTP counter- 
acts such inhibitors of aminoacyl-tRNA binding with 
the ribosome as tetracycline and streptomycin and 
does not counteract erythromycin, spectinomycin 
and chloramphenicol; on the contrary, the elonga- 
tion factor G (EF-G) with GTP proved to be an 
antagonist of erythromycin and spectinomycin which 
are known to be inhibitors of translocation, and did 
not affect the action of tetracyclin and streptomycin 
[l] . However, the fact that EF-G with GTP also 
counteracted chloramphenicol, which is known to be 
an inhibitor of ribosomal transpeptidation, seemed 
unusual. 
In the present work the effect of the elongation 
factors with GTP on the action of some inhibitors of 
bacterial ribosome peptidyl-transferase, such as 
chloramphenicol, lincomycin, amicetin, gougerotin 
and griseoviridin, was studied. The result was 
unexpected: all the tested inhibitors of ribosomal 
peptidyl-transferase were antagonized by EF-G (but 
not EF-T,) with GTP. The result is discussed in the 
light of the concept of reversibility of the transpeptida- 
tion reaction in the ribosome. 
2. Materials and methods 
Escherichia coli MRE-600 ribosomal30 S and 50 S 
subparticles, purified elongation factors EF-T, and 
EF-G and tRNA aminoacylated with [r4C]phenyl- 
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alanine (5 13 Ci/mol, Amersham) were prepared as 
described earlier [2]. 
All the translation systems were prepared in buffer 
containing 10 mM Tris-HCl, 100 mM KCl, 6-13 mM 
MgCls, 1-2 mM dithiothreitol, final pH 7.1-7.4 at 
25°C. The MgClz concentration was 10 mM for the 
factor-free system, 6 mM for the EF-T,-promoted 
system, 13 mM for the EF-G-promoted system and 
10 mM for the (EF-T, t EF-G)-promoted system, 
which corresponds to the Mg2’optima of the respec- 
tive systems [2]. 
In all the cases each 50 /.d sample contained 7 pg 
of 30 S subparticles, 14 Erg of 50 S subparticles, 10 pg 
of poly(U) and 60 fig of total tRNA aminoacylated 
with [14C]phenylalanine. In addition, samples of the 
EF-T, -promoted system contained 1 pg of EF-T, 
and 3 pg of GTP; samples of the EF-G-promoted 
system contained 0.5 pg of EF-G and 3 pg of GTP; 
samples of the (EF-T, t EF-G)-promoted system con- 
tained 1.75 c(g of EF-T,, 0.5 pg of EF-G and 3 pg of 
GTP. 
Incubation of the factor-free system was done for 
3 h at 25°C; incubation of the EF-T,-promoted and 
the EF-G-promoted systems was carried out for 2 h at 
25°C; the (EF-T, + EF-G)-promoted system was 
incubated for 30 min at 25°C. In all cases the end of 
incubation corresponded to the linear region of the 
kinetic curve of polyphenylalanine synthesis in the 
respective system (see [2]). 
Treatment of the samples with hot trichloroacetic 
acid and radioactivity counts were done as described 
earlier [2] . 
Poly(U), dithiothreitol and gougerotin were from 
Calbiochem. GTP was from Fluka, Switzerland. 
Chloramphenicol was provided by Dr Yu. 0. Sazykin, 
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Institute of Antibiotics, Moscow; griseoviridin was a 
gift of Dr D. Vazquez, Instituto de Biologia Cellular, 
Madrid; lincomycin and amicetin were generously 
provided by Dr G. B. Whitfield of the Upjohn Com- 
pany, Kalamazoo, Michigan. 
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3. Results and discussion 20 - 
The contribution of the elongation factors to the 
resistance of ribosomes against inhibitors was studied 
by comparing the inhibitor effect on the factor- 
dependent and factor-free translation systems [ 1 ] . 
Chloramphenicol, lincomycin, amicetin, gougerotin 
and griseoviridin, known to be specific inhibitors of the 
peptidyl-transferase center of bacterial ribosomes 
(see review [3]), were tested. Figure 1 shows the 
dependence of inhibition of the factor-free, the EF-T,- 
promoted, the EF-G-promoted and the (EF-T, + EF-G)- 
promoted poly(U)-directed translation systems on the 
inhibitor doses for the five indicated inhibitors of the 
peptidyl-transferase. It is seen that all the tested anti- 
biotics suppress the factor-free translation very 
effectively. However, in the presence of the two 
elongation factors (EF-T, t EF-G) and GTP, the 
poly(U)-directed translation proves to be much more 
resistant to all the inhibitors of the peptidyl-trans- 
ferase. The most interesting fact is that a similar high 
resistance to the antibiotics is observed in the presence 
of only EF-G with GTP, while the presence of just 
EF-T, with GTP in the system does not contribute to 
the resistance of the ribosome against inhibitors of 
the peptidyl-transferase. 
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Table 1 shows the amount of antibiotic molecules 
per ribosome required for a 50% inhibition of the 
corresponding translation systems. It is seen that the 
factor-free and the EF-T,-promoted systems are 
similarly sensitive to the peptidyl-transferase inhibitors. 
At the same time, both the EF-G-promoted and the 
two-factor-promoted systems require essentially 
greater amounts of antibiotic for the half-inhibition; 
these amounts exceed those in the case of the factor- 
free and EF-T,-promoted systems by at least an order 
of magnitude or more. 
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Hence, it is the presence of EF-G with GTP that 
proves to be necessary and sufficient to strongly 
increase the resistance of translating ribosomes against 
peptidyl-transferase inhibitors. This fact appears to be 
novel and requires special discussion. 
Fig. 1. Dependence of inhibition of the poly(U)-directed 
factor-free (o), the EF-T,-promoted (o), the EF-G-promoted 
(A), and the (EF-T, + EF-G)-promoted (a), translation 
systems on the amount of inhibitor per ribosome. Ribosome 
concentration 1.5 X lo-’ M. (a) chloramphenicol; (b) 
lincomycin; (c) amicetin; (d) gougerotin; (e) griseoviridin. 
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Table 1 
Effect of ribosomal peptidyl-transferase inhibitors on the poly(U)-directed factor-free 
and factor-promoted translation systems 
Antibiotics Number of antibiotic molecules per ribosome resulting in 50% 
inhibition of the system: 
Factor-free EF-T,-promoted EF-G-promoted (EF-Tu + EF-G)- 
promoted 
Chloramphenicol z 300 = 300 >> 10 000 >> 10 000 
Lincomycin = 1000 = 1000 >> 10 000 >> 10 000 
Amicetin 10-20 10-20 > 1000 > 1000 
Gougerotin 100 50 10 000 5000 
Griseoviridin 0.5 0.5 5 5 
The explanation could be a standard one: EF-G 
interacts with the ribosome, and in some way interferes 
with the binding sites of peptidyl-transferase inhibitors. 
Such an explanation, however, seems unlikely for the 
following reasons. (1) EF-G in the process of elonga- 
tion must each time leave the ribosome before or during 
aminoacyl-tRNA binding [4-lo], i.e. in any case 
prior to the transpeptidation reaction which is 
affected by the inhibitors. (2) EF-T,, which interacts 
with the ribosome site common or overlapping with 
the interaction site of EF-G (see the literature cited 
above and also review [ 1 11 ), in no cases counteracts 
the peptidyl-transferase inhibitors (fig.1 and table 1). 
(3) Ribosomal proteins involved in the binding and 
functioning of the elongation factors are different from 
those participating in the peptidyl-transferase center 
(see review [ 111). (4) The tested antibiotics differ by 
their sites of binding with the peptidyl-transferase 
center of the ribosome [3], but nonetheless they all 
are antagonized by EF-G with GTP. 
According to modern concepts, EF-G with GTP in 
the process of elongation comes into operation after 
the transpeptidation reaction (see, for example, 
review [ 121). After formation of the oncoming 
peptide bond, the ribosome becomes competent for 
the binding of EF-G with GTP; the bound EF-G with 
GTP promotes the translocation of newly-formed 
peptidyl-tRNA conjugated with the shifting of mRNA 
and the release of deacylated tRNA. In what way can 
the promotion of translocation affect a preceding 
event such as transpeptidation? 
An explanation can be the following. The reaction 
of transpeptidation in the ribosome is essentially 
reversible. This means that peptidyl-tRNA in the 
pre-translocation state is not yet the final product, 
but must be considered rather as ah&h-energy 
intermediate (e.g., owing to the conformationally 
tense state of the pre-translocation ribosome complex): 
Peptidyl(n)-tRNAbost + Aminoacyl-tRNA~ound 
transpeptidation 
4 * 
e Peptidyl(ntl)-tRNAzre + tRNA)bound 
translocatiop 
___t Peptidyl(ntl)-tRNA~oti + tRNAL,&. 
(where post is the post-translocation state and pre is the 
pre-translocation state of peptidyl-tRNA in the 
ribosome). The reversibility of the transpeptidation 
reaction in the ribosome has been already suggested 
earlier to explain the stimulating effect of EF-G with 
GTP on miscoding [2]. If transpeptidation, until 
translocation takes place, is reversible, then the anti- 
biotics which are competitive inhibitors of substrate 
binding with the peptidyl-transferase center must 
interfere with the direct reaction, but the promotion 
of translocation by EF-G with GTP will draw the pro- 
ducts of the reaction away from the equilibrium and 
thus shift the reaction to the right, i.e. will counter- 
act the antibiotics. 
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